Market Share of Investigational New Drug CDMO Industry
The investigational new drug CDMO market is semi-consolidated, with several companies operating globally. Most companies are engaged in strategic activities like mergers and acquisitions, collaborations, and partnerships to sustain in the market. Some of the key players involved in the market are Lonza, Charles River Laboratories International Inc., Labcorp Corporation, Recipharm AB, and Syneous Health.
Investigational New Drug CDMO Market Leaders
-
Lonza
-
Charles River Laboratories International, Inc.
-
Recipharm AB
-
Syneous Health
-
Labcorp Corporation
*Disclaimer: Major Players sorted in no particular order
